Pharmacist Awareness, Knowledge, and Clinical Engagement of Medication-Related Osteonecrosis of the Jaw: A Survey From a Designated Community Cancer Care Hospital

Introduction Medication-related osteonecrosis of the jaw (MRONJ) is a clinically challenging condition; however, the actual practice and interprofessional engagement of pharmacists regarding MRONJ remain undetermined. We assessed the awareness, knowledge, and clinical engagement regarding MRONJ among pharmacists working at a cancer care hospital, identified the gaps between theoretical understanding and actual clinical practice, and explored strategies for enhancing interprofessional collaboration and educational support. Methods In this cross-sectional survey, we administered a web-based anonymous questionnaire to 65 pharmacists working at the hospital between February 19 and March 18, 2024. The questionnaire covered topics including pharmacist demographics, clinical experience with bone-modifying agents (BMAs), understanding of MRONJ, and experiences with interprofessional collaborations in dental care. Results Response rate was 78.5% (51/65). Most respondents were in their 20s or 30s (33.3% for both age groups) and had <10 years of professional experience. Approximately 90% were aware of MRONJ; however, only 3.9% had encountered an actual case. Many pharmacists demonstrated an understanding of the link between BMAs and MRONJ; however, only 21.6% reported that they "sometimes" assessed oral conditions during medication counseling, and none reported doing so "always." Notably, 45.1% pharmacists reported difficulties in collaborating with dentists, and overall interprofessional engagement remained limited. Most pharmacists expressed a positive attitude toward interprofessional collaborations, and 98.0% acknowledged the importance of working with dental professionals. However, none had provided oral health information to external dental clinics. Conclusions There is a gap between the theoretical knowledge of MRONJ among pharmacists and their clinical experience. Their limited involvement in outpatient dental care suggests the presence of structural barriers. Interprofessional collaboration and educational support systems need enhancement.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-09-09
DOI
https://doi.org/10.7759/cureus.91892
Primary Topic
Bone health and treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pharmacist Awareness, Knowledge, and Clinical Engagement of Medication-Related Osteonecrosis of the Jaw: A Survey From a Designated Community Cancer Care Hospital

Takahiro Kaneko, Miki Yamada, Norio Horie, Yosuke Iijima et al.
Cureus
Bone health and treatments
article

Pharmacist Awareness, Knowledge, and Clinical Engagement of Medication-Related Osteonecrosis of the Jaw: A Survey From a Designated Community Cancer Care Hospital

Takahiro Kaneko, Miki Yamada, Norio Horie, Yosuke Iijima, Hiroki Ohya, Saya Watanabe, Kenta Ushikubo, Atsunobu Sagara, Masafumi Morimoto, Motohiko Sano
article en

Abstract

Introduction Medication-related osteonecrosis of the jaw (MRONJ) is a clinically challenging condition; however, the actual practice and interprofessional engagement of pharmacists regarding MRONJ remain undetermined. We assessed the awareness, knowledge, and clinical engagement regarding MRONJ among pharmacists working at a cancer care hospital, identified the gaps between theoretical understanding and actual clinical practice, and explored strategies for enhancing interprofessional collaboration and educational support. Methods In this cross-sectional survey, we administered a web-based anonymous questionnaire to 65 pharmacists working at the hospital between February 19 and March 18, 2024. The questionnaire covered topics including pharmacist demographics, clinical experience with bone-modifying agents (BMAs), understanding of MRONJ, and experiences with interprofessional collaborations in dental care. Results Response rate was 78.5% (51/65). Most respondents were in their 20s or 30s (33.3% for both age groups) and had <10 years of professional experience. Approximately 90% were aware of MRONJ; however, only 3.9% had encountered an actual case. Many pharmacists demonstrated an understanding of the link between BMAs and MRONJ; however, only 21.6% reported that they "sometimes" assessed oral conditions during medication counseling, and none reported doing so "always." Notably, 45.1% pharmacists reported difficulties in collaborating with dentists, and overall interprofessional engagement remained limited. Most pharmacists expressed a positive attitude toward interprofessional collaborations, and 98.0% acknowledged the importance of working with dental professionals. However, none had provided oral health information to external dental clinics. Conclusions There is a gap between the theoretical knowledge of MRONJ among pharmacists and their clinical experience. Their limited involvement in outpatient dental care suggests the presence of structural barriers. Interprofessional collaboration and educational support systems need enhancement.

CureusVol. 17(9)
Jichi Medical University (JP), Hoshi University (JP), Japanese Red Cross Medical Center (JP), Jichi Medical University Saitama Medical Center (JP), Saitama Medical University (JP)
Saitama Medical University
Openalex Percentile: Top 66%
Bone health and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.